clinical trials Archives | Cannabiz

News in brief: Judgment reserved in CDA Clinics QLD legal case; Nexalis completes Phase 1 IRX-616a dosing

by Adam Sheldon May 18, 2026May 21, 2026

A judgment in the long-running legal dispute between the Therapeutic Goods Administration and CDA Clinics Queensland […]

News in brief: Nexalis advances IRX-616a and IRX-211 programs; Vitura heralds Doctors on Demand growth; Elixinol improves cash flow

by Adam Sheldon April 20, 2026April 22, 2026

News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial

by Adam Sheldon March 17, 2026March 17, 2026

News in brief: Avecho gains key patent allowances; Montu expands medical affairs team

by Adam Sheldon December 9, 2025February 21, 2026

Failed clinical trial highlights perils of medicinal cannabis research

by Adam Sheldon September 30, 2025October 1, 2025

Cannabinoid Oil In Laboratory - Medical Cannabis Australia - Cannabiz

Family experience of MC drives Medibis to fund autism anxiety trial

by Adam Sheldon August 5, 2025August 19, 2025

From tracking app to industry ally: OnTracka’s critical role in shifting the cannabis needle

by Steve Jones May 13, 2025May 15, 2025

Manufacturer and supplier iX Biopharma insists finances are secure despite auditor concerns

by Steve Jones October 9, 2024October 10, 2024

Cannabinoid Oil In Laboratory - Medical Cannabis Australia - Cannabiz

Number of clinical trials using cannabis ‘exploded’ in last decade

by Martin Lane September 1, 2023April 30, 2024

Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix

by Steve Jones and Martin Lane April 5, 2023April 30, 2024